In vitro percutaneous absorption of ondansetron hydrochloride from pressure-sensitive adhesive matrices through hairless mouse skin

Archives of Pharmacal Research

Volumn 26, Issue 8, 2003, Pages 644-648

  Hye, Sun Gwak ^b   Ik, Sang Oh ^a   In, Koo Chun ^a  

^a Dongduk Women's University   (South Korea)

^b Chosun University   (South Korea)

Author keywords

Ondansetron transdermal system; Permeation; Pressure sensitive adhesive matrices; Release; Vehicles

Indexed keywords

ADHESIVE AGENT; ONDANSETRON;

ANIMAL; ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFECT; HAIRLESS MOUSE; IN VITRO STUDY; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; MOUSE; PRESSURE; SKIN; SKIN ABSORPTION;

ADHESIVES; ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; MALE; MICE; MICE, INBRED HRS; ONDANSETRON; PRESSURE; SKIN; SKIN ABSORPTION;

EID: 2342614968     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/bf02976714     Document Type: Article

References (19)

1. Aungst, B. J., Blake, J. A., and Hussain, M. A., Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res., 7, 712-718 (1990).
2. Barry, B. W., Mode of action of penetration enhancers in human skin. J. Contr. Res., 6, 85-97 (1987).
3. Blackwell, C. P. and Harding, S. M., The clinical pharmacology of ondansetron. Eur. J. Cancer Clin. Oncol., 25 (Suppl 1), S21-S24 (1989).
4. Butcher, M. E., Global experience with ondansetron and future potential. Oncology, 50, 191-197 (1993).
5. Chien, Y. W. and Lambert, H. J., Controlled drug release from polymeric delivery devices II: differentiation between partition-controlled and matrix-controlled drug release mechanism. J. Pharm. Sci., 63, 515-519 (1974).
6. Cho, Y. J. and Choi, H. K., Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix . Int. J. Pharm.,169, 95-104 (1998).
7. Green, P. G., Guy, R. H., and Hadgraft, J., In vitro and in vivo enhancement of skin permeation with oleic and lauric acids . Int. J. Pharm., 48, 103-111 (1988).
8. Gwak, H. S. and Chun, I. K., Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int. J. Pharm., 236, 57-64 (2002).
9. Gwak, H. S., Kim, S. U., and Chun, I. K., Effect of vehicles and enhancers on the in vitro permeation of melatonin through hairless mouse skin. Arch. Pharm. Res., 25, 392-396 (2002).
10. Gwak, H. S., Oh, I. S., and Chun, I. K., Transdermal delivery of ondansetron hydrochloride: effect of vehicles and penetration enhancers. Drug Dev. Ind. Pharm., accepted (2003a).
11. Gwak, H. S., Oh, I. S., and Chun, I. K., Solubility and physicochemical stability of ondansetron hydrochloride in various vehicles. J. Kor. Pharm. Sci., 33, 45-49 (2003b).
12. Hesketh, P. J. and Gandara, D. R., Serotonin antagonists: a new class of antiemetic agents. J. Natl. Cancer Inst., 83, 613-620 (1991).
13. McKenzie, R., Kovac, A., O'Connor, T., Duncalf, D., Angel, J., Gratz, I., Tolpin, E., McLeskey, C., and Joslyn, A., Comparison of ondansetron versus placebo to prevent postoperative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology, 78, 21-28 (1993).
14. Møllgard, B. and Hoelgaard, A., Vehicle effect in topical drug delivery I. Influence of glycols and drug concentration on skin transport. Acta. Pharm. Suec., 20, 433-442 (1983).
15. Nokhodchi, A., Shokri, J., Dashbolaghi, A., Hassan-Zadeh, D., Ghafourian, T., and Barzegar-Jalali, M., The enhancement effect of surfactants on the penetration of lorazepam through rat skin. Int. J. Pharm., 250, 359-369 (2003).
16. Roy, S. D., Gutierrez, M, Flynn, G. L., and Cleary, G. W., Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design. J. Pharm. Sci., 85, 491-495 (1996).
17. Santoyo, S., Arellano, A., Ygartua, P., and Martin, C., Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int. J. Pharm., 117, 219-224 (1995).
18. Scuderi, P., Wetchler, B., Sung, Y. F., Mingus, M., DuPen, S., Claybon, L., Leslie, J., Talke, P., Apfelbaum, J., and Sharifi-Azad, S., Treatment of postoperative nausea and vomiting after outpatient surgery with the 5-HT3 antagonist ondansetron. Anesthesiology, 78, 15-20 (1993).
19. Yamada, M., Uda, Y., and Tanigawara, Y., Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid. Chem. Pharm. Bull., 35, 3399-3406 (1987).